Published in Clin Infect Dis on January 01, 1998
Tickborne relapsing fever diagnosis obscured by malaria, Togo. Emerg Infect Dis (2007) 1.83
Borrelia hispanica relapsing fever, Morocco. Emerg Infect Dis (2009) 1.40
Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice. Infect Immun (1999) 1.25
The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J Clin Invest (1999) 1.22
The epidemiology and geographic distribution of relapsing fever borreliosis in West and North Africa, with a review of the Ornithodoros erraticus complex (Acari: Ixodida). PLoS One (2013) 1.16
Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells. Infect Immun (2001) 1.13
Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun (2001) 1.11
Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. Infect Immun (2001) 1.09
Meningoencephalitis complicating relapsing fever in traveler returning from Senegal. Emerg Infect Dis (2012) 0.97
Molecular identification of Borrelia crocidurae in a patient returning from Senegal. BMJ Case Rep (2009) 0.93
A disconnect between the neurospirochetoses in humans and rodent models of disease. PLoS Pathog (2013) 0.91
Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever. Proc Natl Acad Sci U S A (2011) 0.90
Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system. Infect Immun (2006) 0.88
The mammalian host response to borrelia infection. Wien Klin Wochenschr (2006) 0.87
Structure-function investigation of vsp serotypes of the spirochete Borrelia hermsii. PLoS One (2009) 0.86
Concomitant infection decreases the malaria burden but escalates relapsing fever borreliosis. Infect Immun (2010) 0.85
Interleukin 10 protects the brain microcirculation from spirochetal injury. J Neuropathol Exp Neurol (2008) 0.83
Testicular damage by microcirculatory disruption and colonization of an immune-privileged site during Borrelia crocidurae infection. J Exp Med (2001) 0.83
Relapsing fever borreliosis in interleukin-10-deficient mice. Infect Immun (2008) 0.82
Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection. Infect Immun (2010) 0.82
Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI. Infect Immun (2013) 0.81
Borrelia crocidurae meningoencephalitis, West Africa. Emerg Infect Dis (2013) 0.81
Understanding tropism and immunopathological mechanisms of relapsing fever spirochaetes. Clin Microbiol Infect (2009) 0.81
The case for a 'one health' approach to combating vector-borne diseases. Infect Ecol Epidemiol (2015) 0.78
The Borrelia hermsii factor H binding protein FhbA is not required for infectivity in mice or for resistance to human complement in vitro. Infect Immun (2014) 0.78
Toward a better understanding of European lyme neuroborreliosis. Clin Infect Dis (2013) 0.77
Cerebral sinuvenous thrombosis associated with Lyme neuroborreliosis. J Neurol (2009) 0.77
Borrelia persica Infection in Immunocompetent Mice - A New Tool to Study the Infection Kinetics In Vivo. PLoS Negl Trop Dis (2016) 0.77
Tick-borne relapsing fever: conjunctival haemorrhages. BMJ Case Rep (2009) 0.76
Interaction of variable bacterial outer membrane lipoproteins with brain endothelium. PLoS One (2010) 0.76
Hemorrhagic Diathesis in Borrelia recurrentis Infection Imported to Germany. Emerg Infect Dis (2016) 0.75
Molecular Evidence of Malaria and Zoonotic Diseases among Rapid Diagnostic Test-Negative Febrile Patients in Low-Transmission Season, Mali. Am J Trop Med Hyg (2016) 0.75
Tick-Borne Relapsing Fever, Southern Spain, 2004-2015. Emerg Infect Dis (2016) 0.75
A 13-year old girl with pancytopenia at the presentation of a Borrelia hispanica infection: a case report and review of the literature. J Med Case Rep (2017) 0.75
Tick-Borne Relapsing Fever in Dogs. J Vet Intern Med (2016) 0.75
Lyme disease-a tick-borne spirochetosis? Science (1982) 27.50
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun (1983) 9.60
Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. J Infect Dis (1985) 7.69
A Borrelia-specific monoclonal antibody binds to a flagellar epitope. Infect Immun (1986) 6.80
Variation in a major surface protein of Lyme disease spirochetes. Infect Immun (1984) 6.68
Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol (1989) 6.51
Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 6.36
Biology of Borrelia species. Microbiol Rev (1986) 6.03
Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science (1987) 5.80
Variable major proteins of Borrellia hermsii. J Exp Med (1982) 5.62
Natural Distribution of the Ixodes dammini spirochete. Science (1983) 5.24
Antigenic variability of Borrelia burgdorferi. Ann N Y Acad Sci (1988) 5.02
Spirochetes in Ixodes dammini and mammals from Connecticut. Am J Trop Med Hyg (1983) 4.86
Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect Immun (1992) 4.42
Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii. Nature (1985) 4.41
Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent. Proc Natl Acad Sci U S A (1989) 4.38
Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia. Cell (1985) 3.78
The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun (1993) 3.50
A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science (1985) 3.42
Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit. Infect Immun (1986) 3.39
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med (1992) 3.30
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
Erythema chronicum migrans--a tickborne spirochetosis. Acta Trop (1983) 2.85
Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi. Infect Immun (1989) 2.76
DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71
Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins. Infect Immun (1992) 2.67
Cloning of 18S and 25S rDNAs from the pathogenic fungus Cryptococcus neoformans. J Bacteriol (1989) 2.55
The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg (1985) 2.50
Linear- and circular-plasmid copy numbers in Borrelia burgdorferi. J Bacteriol (1992) 2.45
High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Infect Immun (1995) 2.39
Polymorphisms of major surface proteins of Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 2.33
In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis (1993) 2.31
Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr Purif (1990) 2.23
Linear plasmids of Borrelia burgdorferi have a telomeric structure and sequence similar to those of a eukaryotic virus. J Bacteriol (1991) 2.15
Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun (1987) 2.15
Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides. J Exp Med (1985) 2.12
Enzyme-linked immunosorbent assays for Lyme disease: reactivity of subunits of Borrelia burgdorferi. J Infect Dis (1989) 2.12
An outbreak of giardiasis in a group of campers. Am J Trop Med Hyg (1976) 2.04
The relapsing fever agent Borrelia hermsii has multiple copies of its chromosome and linear plasmids. Genetics (1992) 2.00
Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun (1993) 1.98
A flagella-less mutant of Borrelia burgdorferi. Structural, molecular, and in vitro functional characterization. J Clin Invest (1991) 1.95
A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun (1994) 1.89
Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii. Proc Natl Acad Sci U S A (1990) 1.87
Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome. Infect Immun (1981) 1.84
Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA (1996) 1.82
An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo. Infect Immun (1993) 1.79
Nucleotide sequence and analysis of the gene in Borrelia burgdorferi encoding the immunogenic P39 antigen. FEMS Microbiol Lett (1994) 1.77
In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol (1992) 1.75
Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Infect Immun (1999) 1.74
Immunochemical analysis of Lyme disease spirochetes. Yale J Biol Med (1985) 1.74
Expert advice and patient expectations: laboratory testing and antibiotics for Lyme disease. JAMA (1998) 1.73
Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med (1994) 1.73
Properties of penicillin-binding proteins in Neisseria gonorrhoeae. Antimicrob Agents Chemother (1981) 1.72
Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol (1985) 1.71
Antigenic variation and strain heterogeneity in Borrelia spp. Res Microbiol (1993) 1.60
Subtelomeric expression regions of Borrelia hermsii linear plasmids are highly polymorphic. Mol Microbiol (1992) 1.55
Cloning and sequence analysis of linear plasmid telomeres of the bacterium Borrelia burgdorferi. Mol Microbiol (1990) 1.54
The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome. Mol Microbiol (1990) 1.52
Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infect Immun (1997) 1.51
Occupational lead poisoning in the United States: clinical and biochemical findings related to blood lead levels. Br J Ind Med (1979) 1.50
Structural analysis of the variable major proteins of Borrelia hermsii. J Exp Med (1983) 1.50
Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization. Infect Immun (1995) 1.49
Antigen diversity in the bacterium B. hermsii through "somatic" mutations in rearranged vmp genes. Cell (1994) 1.44
Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae. Infect Immun (1997) 1.42
Action of penicillin on Borrelia hermsii. Antimicrob Agents Chemother (1982) 1.42
Comparative analysis and immunological characterization of the Borrelia Bdr protein family. Infect Immun (1999) 1.40
Population structure of the relapsing fever spirochete Borrelia hermsii as indicated by polymorphism of two multigene families that encode immunogenic outer surface lipoproteins. Infect Immun (1998) 1.40
Antibodies to Lyme-disease spirochaete in European lymphocytic meningoradiculitis (Bannwarth's syndrome) Lancet (1983) 1.39
Isolation of a spirochete from the soft tick, Ornithodoros coriaceus: a possible agent of epizootic bovine abortion. Science (1985) 1.39
The etiologic agent of Lyme disease in deer flies, horse flies, and mosquitoes. J Infect Dis (1986) 1.38
Bacteriophage in the Ixodes dammini spirochete, etiological agent of Lyme disease. J Bacteriol (1983) 1.38
Activation of a vmp pseudogene in Borrelia hermsii: an alternate mechanism of antigenic variation during relapsing fever. Mol Microbiol (1994) 1.36
Conversion of a linear to a circular plasmid in the relapsing fever agent Borrelia hermsii. J Bacteriol (1996) 1.31
A surface-exposed region of a novel outer membrane protein (P66) of Borrelia spp. is variable in size and sequence. J Bacteriol (1998) 1.30
Surface exposure and species specificity of an immunoreactive domain of a 66-kilodalton outer membrane protein (P66) of the Borrelia spp. that cause Lyme disease. Infect Immun (1996) 1.30
Male ticks help their mates to feed. Nature (1998) 1.29
Expression of the flagellin gene in Borrelia is controlled by an alternative sigma factor. Microbiology (1995) 1.29
Chemiluminescence by polymorphonuclear leukocytes from patients with active bacterial infection. J Infect Dis (1980) 1.26
Extensive interplasmidic duplications change the virulence phenotype of the relapsing fever agent Borrelia turicatae. Mol Microbiol (1999) 1.26
Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice. Infect Immun (1999) 1.25
A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun (1994) 1.24
Detection of Borrelia burgdorferi DNA by the polymerase chain reaction. Mol Cell Probes (1990) 1.24
In vitro activity of vancomycin against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother (1993) 1.23
The extended promoters for two outer membrane lipoprotein genes of Borrelia spp. uniquely include a T-rich region. Mol Microbiol (1999) 1.22
An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J Infect Dis (1997) 1.22
Analysis of promoters in Borrelia burgdorferi by use of a transiently expressed reporter gene. J Bacteriol (1997) 1.21
Lyme disease in Wisconsin: epidemiologic, clinical, serologic, and entomologic findings. Yale J Biol Med (1985) 1.18
Identification of the tick-borne relapsing fever spirochete Borrelia hermsii by using a species-specific monoclonal antibody. J Clin Microbiol (1992) 1.16
Extrachromosomal elements of spirochetes. Res Microbiol (1993) 1.13
Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun (2001) 1.11
Taxonomy of Borrelia spp. Scand J Infect Dis Suppl (1991) 1.11
Structural conservation of neurotropism-associated VspA within the variable Borrelia Vsp-OspC lipoprotein family. J Biol Chem (2001) 1.10
OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks. Vector Borne Zoonotic Dis (2001) 1.09
Immunobiology of relapsing fever. Contrib Microbiol Immunol (1987) 1.09
Experimental infection of the mouse brain by a relapsing fever Borrelia species: a molecular analysis. J Infect Dis (1993) 1.07